Clinical trial
TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single…
NCT00292474 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00292474 |
|---|---|
| Title | TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent |
| Official title | TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | percutaneous coronary intervention |
| Enrollment | 1,326 |
| Start date | Mar 1, 2002 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Feb 16, 2006 |
| Last update posted | Oct 8, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: